Eloxx Pharmaceuticals, Inc.ELOX
Price (close)
$15.03
Market cap
$5.2M
P/E
—
Revenue (FY)
$0
Net income
-$6.0M
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
-100.0%
Debt / equity
—
What Eloxx Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $6.4M | $0 |
| Net income | -$34.6M | -$66.7M | -$36.1M | -$17.1M | -$3.1M | -$6.0M |
| Free cash flow | — | -$35.1M | -$31.9M | — | — | — |
More on ELOX.
- Eloxx Pharmaceuticals, Inc. summary
- Eloxx Pharmaceuticals, Inc. financial statements
- Eloxx Pharmaceuticals, Inc. key metrics
- Eloxx Pharmaceuticals, Inc. health scores and style box
- Eloxx Pharmaceuticals, Inc. earnings
- Eloxx Pharmaceuticals, Inc. dividends
- Eloxx Pharmaceuticals, Inc. valuation
- Eloxx Pharmaceuticals, Inc. ownership and insiders
- Eloxx Pharmaceuticals, Inc. peers
Figures from Eloxx Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.